RecruitingEarly Phase 1NCT04930991

High Dose Omeprazole in Patients With Pancreatic Cancer

A Phase 0 Study of High Dose Omeprazole in Patients With Pancreatic Cancer Planning to Undergo Surgical Therapy for Evaluating Changes of Biomarkers


Sponsor

University of Oklahoma

Enrollment

60 participants

Start Date

Sep 7, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to test the safety of high dose omeprazole and see what effects that it has on patients with exocrine pancreatic cancer.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether taking high doses of omeprazole (a common heartburn/acid-reflux medication) before surgery might help fight pancreatic cancer by making the tumor's environment more acidic and less favorable to cancer cells. **You may be eligible if...** - You have been newly diagnosed with pancreatic cancer (adenocarcinoma type), confirmed by imaging or biopsy - You are a candidate for surgical removal of your pancreatic cancer - You are 18 or older and in generally good health (ECOG 0-2) - You are not pregnant **You may NOT be eligible if...** - Your pancreatic cancer cannot be surgically removed - You have already had surgery for pancreatic cancer - You are pregnant or breastfeeding - You have a serious allergy or medical condition that prevents participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGOmeprazole

Treatment will consist of Omeprazole 12-14 days prior to surgical therapy of pancreatectomy.


Locations(1)

Stephenson Cancer Center

Oklahoma City, Oklahoma, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04930991


Related Trials